Utility of contrast-enhanced MRI radiomics features combined with clinical indicators for predicting induction chemotherapy response in primary central nervous system lymphoma
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s11060-023-04554-6.pdf
Reference28 articles.
1. Yu J, Du H, Ye X, Zhang L, Xiao H (2021) High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: Meta-analysis of clinical trials. Sci Rep 11:2125. https://doi.org/10.1038/s41598-020-80724-0
2. Ferreri A, Calimeri T, Cwynarski K, Dietrich J, Grommes C, Hoang-Xuan K et al (2023) Primary central nervous system lymphoma. Nat Rev Dis Primers 9:29. https://doi.org/10.1038/s41572-023-00439-0
3. Huang WY, Wen JB, Wu G, Yin B, Li JJ, Geng DY (2016) Diffusion-Weighted imaging for predicting and monitoring primary central nervous system lymphoma treatment response. AJNR Am J Neuroradiol 37:2010–2018. https://doi.org/10.3174/ajnr.A4867
4. Fu F, Sun X, Li Y, Liu Y, Shan Y, Ji N et al (2021) Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict chemotherapeutic responses and survival in primary central-nervous-system lymphoma. Eur Radiol 31:1863–1871. https://doi.org/10.1007/s00330-020-07296-5
5. Deguchi S, Nakashima K, Muramatsu K, Mitsuya K, Oishi T, Shirata K et al (2019) Pretreatment intratumoral susceptibility signals correlate with response to high-dose methotrexate and progression-free survival in primary central nervous system lymphoma. J Clin Neurosci 69:43–50. https://doi.org/10.1016/j.jocn.2019.08.039
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MRI-based radiomics signatures for preoperative prediction of Ki-67 index in primary central nervous system lymphoma;European Journal of Radiology;2024-09
2. Primary central nervous system lymphomas in immunocompromised patients require specific response criteria;Journal of Neuro-Oncology;2024-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3